Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cara Therapeutics Inc CARA

Healthcare Cannabis
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated... see more

Recent & Breaking News (NDAQ:CARA)

Cara Therapeutics to Present at the 2018 Cantor Global Healthcare Conference

GlobeNewswire September 26, 2018

The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding

Benzinga.com  September 21, 2018

Cara Therapeutics to Present at the 27th European Academy of Dermatology & Venereology Congress

GlobeNewswire September 5, 2018

Cara Therapeutics Reports Second Quarter 2018 Financial Results

GlobeNewswire August 7, 2018

Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus

GlobeNewswire August 7, 2018

Cara Therapeutics Appoints Christopher A. Posner to Board of Directors

GlobeNewswire August 6, 2018

Cara Therapeutics to Announce Second Quarter 2018 Financial Results on August 7, 2018

GlobeNewswire July 31, 2018

Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire July 23, 2018

Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock

GlobeNewswire July 18, 2018

Cara Therapeutics Announces Proposed Offering of Common Stock

GlobeNewswire July 17, 2018

Canadian Cannabis Market is Projected to Rival California's

PR Newswire July 11, 2018

Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients

GlobeNewswire July 11, 2018

The Wave of Cannabis Legalization is Impending Abroad

PR Newswire July 5, 2018

Thinking about buying stock in Alibaba, Cara Therapeutics, China Lending, Helios and Matheson Analytics Inc., or World Wrestling Entertainment?

PR Newswire June 27, 2018

Cara Therapeutics Reports Positive Top-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery

GlobeNewswire June 27, 2018

Additional Adult-use Applications of Cannabis are Pushing the Market Upward

PR Newswire June 21, 2018

Factors of Influence in 2018, Key Indicators and Opportunity within Camden National, Cara Therapeutics, Albany International, Emerge Energy Services LP, Fiesta Restaurant Group, and Resources Connection — New Research Emphasizes Economic Growth

GlobeNewswire June 21, 2018

International Cannabis Legalization to Spur Global Medical and Recreational Sales

PR Newswire June 13, 2018

Cara Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

GlobeNewswire May 29, 2018

Mid-Day Market Update: Dow Falls Over 100 Points; Cara Therapeutics Shares Spike Higher

Benzinga.com  May 23, 2018